TG Therapeutics Inc (NASDAQ:TGTX)

7.57
Delayed Data
As of Nov 12
 -0.22 / -2.82%
Today’s Change
3.32
Today|||52-Week Range
9.38
+84.63%
Year-to-Date

Today’s Trading

Previous close7.79
Today’s open7.55
Day’s range7.31 - 7.91
Volume1,387,493
Average volume (3 months)1,153,732
Market cap$773.7M
Data as of 4:00pm ET, 11/12/2019

Growth & Valuation

Earnings growth (last year)-20.36%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-0.25%
P/E ratioNM
Price/Sales2,035.62
Price/Book28.49

Competitors

 Today’s
change
Today’s
% change
HSKAHeska Corp+2.84+3.18%
KURAKura Oncology Inc+0.05+0.32%
TXMDTherapeuticsMD Inc-0.12-4.21%
RVNCRevance Therapeutics...+0.05+0.33%
Data as of 4:00pm ET, 11/12/2019

Financials

Next reporting dateMarch 5, 2020
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$152.0K
Annual profit (last year)-$173.5M
Net profit margin-114,132.89%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
New York, New York

Forecasts